Immutep Company Insiders

IMMP Stock  USD 1.93  0.09  4.89%   
Immutep employs about 8 people. The company is managed by 8 executives with a total tenure of roughly 8 years, averaging almost 1.0 years of service per executive, having 1.0 employees per reported executive. Discussion of Immutep's management performance can provide insight into the enterprise performance.
Marc Voigt  CEO
CEO, Executive Director
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Immutep Management Team Effectiveness

The company has return on total asset (ROA) of (0.1667) % which means that it has lost $0.1667 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2621) %, meaning that it created substantial loss on money invested by shareholders. Immutep's management efficiency ratios could be used to measure how well Immutep manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/23/2024, Return On Tangible Assets is likely to drop to -0.27. In addition to that, Return On Capital Employed is likely to drop to -0.31. At this time, Immutep's Total Current Liabilities is relatively stable compared to the past year. As of 11/23/2024, Liabilities And Stockholders Equity is likely to grow to about 211.7 M, while Non Current Liabilities Total is likely to drop slightly above 1.5 M.
As of 11/23/2024, Common Stock Shares Outstanding is likely to grow to about 1.3 B, while Net Loss is likely to drop (37.7 M).

Immutep Workforce Comparison

Immutep Ltd ADR is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 106. Immutep adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Immutep Ltd ADR Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Immutep Ltd ADR Price Series Summation is a cross summation of Immutep price series and its benchmark/peer.

Immutep Notable Stakeholders

An Immutep stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Immutep often face trade-offs trying to please all of them. Immutep's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Immutep's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Marc VoigtCEO, Executive DirectorProfile
Deanne LLBGeneral COOProfile
Frederic MDChief DirectorProfile
Indira NaiduJoint SecretaryProfile
Christian MuellerDirector AffairsProfile
Shengfei FangF SecProfile
MD MScChief OfficerProfile
MSc BBASenior StrategyProfile

About Immutep Management Performance

The success or failure of an entity such as Immutep Ltd ADR often depends on how effective the management is. Immutep management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Immutep management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Immutep management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.26)(0.27)
Return On Capital Employed(0.29)(0.31)
Return On Assets(0.24)(0.26)
Return On Equity(0.26)(0.28)

Immutep Workforce Analysis

Traditionally, organizations such as Immutep use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Immutep within its industry.

Immutep Manpower Efficiency

Return on Immutep Manpower

Revenue Per Employee480.2K
Revenue Per Executive480.2K
Net Loss Per Employee5.3M
Net Loss Per Executive5.3M
Working Capital Per Employee15.6M
Working Capital Per Executive15.6M

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.